RedShiftBio
Dennis Merrill has over 20 years of experience in engineering and product development. Dennis currently holds the position of Vice President of Engineering and Product Development at RedShiftBio since May 2020. Prior to this, they served as the Vice President of Engineering at Headwall Photonics from March 2019 to May 2020. From August 2016 to March 2019, they worked as the Chief Technology Officer at Galaxy Scientific, and from December 2013 to August 2016, they held the role of VP of R&D at the same company. Before joining Galaxy Scientific, Dennis served as the VP of Engineering at Rigaku from January 2013 to December 2013. Dennis played a significant role as the VP of Engineering at EyeNetra, a MIT Media Lab spin-out company focusing on revolutionizing eye care from September 2012 to January 2013. Prior to that, they worked at Thermo Fisher Scientific for over 15 years, where they held various positions including Senior Director of Product Development and Engineering Manager.
Dennis Merrill has a Bachelor of Science in Electrical Engineering (BSEE) from the University of Wisconsin-Platteville, which they earned from 1993 to 1997. Dennis later pursued a Master of Business Administration (MBA) degree from the MIT Sloan School of Management from 2011 to 2013. In 2009 to 2010, they attended the University of Wisconsin-Madison, though there is no information provided regarding the degree or field of study during this period.
RedShiftBio
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a MicrofluidicModulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind.The company was founded in 2005 and is headquartered in Burlington, Massachusetts.